Clinical Study

Prevalence of Primary Aldosteronism in Patients With Resistant Hypertension in China

Summary

Recent studies indicate that primary aldosteronism (PA) is a much more common cause of hypertension than had been demonstrated historically. In patients with resistant hypertension, the prevalence of PA from different clinics worldwide is about 10-20%. As has been no such data in China, the investigators are conducting a PA study in different province of China to evaluate the prevalence of PA in patients with resistant hypertension.

Study Name: Prevalence of Primary Aldosteronism and Status of Renin-Angiotensin System in Resistant Hypertension: An Observational Study in China

Status: Completed

Conditions: Primary aldosteronism

Interventions: Observational

Locations: Shanghai Jiao Tong University School of Medicine

Study link: https://clinicaltrials.gov/study/NCT01459042

To search for other studies by topic, location, or status, go to our Clinical Studies page.